Flavie Strappazzon

11PUBLICATIONS
24CO-AUTHORS
NeurogeneticsAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Speciation and extinctionAutomotive safety engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 20, 2026
A fetus with severe developmental defects caused by dominant-negative and hypomorphic ATG7 alleles.

|Dec 30, 2025
Autophagy and selective autophagy receptors: Key players against Alzheimer's disease.

Krenare Bruqi, Flavie Strappazzon

|May 21, 2025
Combining doxorubicin and miR-218-5p: a new strategy to fight breast cancer?

Francesco Davide Naso, Flavie Strappazzon

|May 03, 2025
NDP52 and its emerging role in pathogenesis.

Krenare Bruqi, Flavie Strappazzon

|Apr 15, 2025
A variant of the autophagic receptor NDP52 counteracts phospho-TAU accumulation and emerges as a protective factor for Alzheimer's disease.

Anna Mattioni, Claudia Carsetti, Krenare Bruqi

|Mar 22, 2024
miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibition.

Francesco Davide Naso, Krenare Bruqi, Valeria Manzini

Pageof 2

Frequent Collaborators

4 joint publications

Francesco Cecconi

2 joint publications

Silvia Campello

2 joint publications

Pasquale D'Acunzo

1 joint publications

Francesca Nazio